• 1
    Hasler WL, Owyang C. Irritable bowel syndrome. In: YamadaT. ed . Textbook of Gastroenterology, Vol. 2. Philadelphia: J.B. Lippincott Company, 1995: 1832.
  • 2
    Collins SM. Is the irritable gut an inflamed gut? Scand J Gastroenterol 1992; 27(Suppl. 192): 1025.
  • 3
    Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: 212037.
  • 4
    Labus JS, Mayer EA, Chang L, Bolus R, Naliboff BD. The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index. Psychosom Med 2007; 69: 8998.
  • 5
    Ladep NG, Obindo TJ, Audu MD, Okeke EN, Malu AO. Depression in patients with irritable bowel syndrome in Jos, Nigeria. World J Gastroenterol 2006; 12: 78447.
  • 6
    Drossman DA. Rome II: functional gastrointestinal disorders. McLean: Degnon Associates, Inc., 2000.
  • 7
    McKendrick MW, Read NW. Irritable bowel syndrome – post salmonella infection. J Infection 1994; 29: 13.
  • 8
    Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997; 314: 77982.
  • 9
    Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow-up study. Gut 2002; 51: 4103.
  • 10
    Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44: 4006.
  • 11
    Gwee KA, Graham JC, McKendrick MW, Collins SM, Marshall JS, Walters SJ, Read NW. Psychometric scores and persistence of irritable bowel after infectious diarrhea. Lancet 1996; 347: 1503.
  • 12
    Moss-Morris R, Spence M. To “lump” or to “split” the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosom Med 2006; 68: 4639.
  • 13
    Borgaonkar MR, Ford DC, Marshall JK, Churchill E, Collins SM. The incidence of irritable bowel syndrome among community subjects with previous enteric infection. Dig Dis Sci 2006; 51: 102632.
  • 14
    Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53: 109611.
  • 15
    Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. Brit Med J 1999; 318: 5656.
  • 16
    Thornley JP, Jenkins D, Neal K, et al. Relationship of Campylobacter toxigenicity in vitro to the development of post-infectious irritable bowel syndrome. J Infect Dis 2001; 184: 6069.
  • 17
    Ji S, Park H, Lee D, Song YK, Choi JP, Lee SI. Post-infectious irritable bowel syndrome in patients with Shigella infection. J Gastroenterol Hepatol 2005; 20: 3816.
  • 18
    Ilnyckyj A, Balachandra B, Elliott L, Choudhri S, Duerksen DR. Post-traveler’s diarrhea irritable bowel syndrome: a prospective study. Am J Gastroenterol 2003; 98: 5969.
    Direct Link:
  • 19
    Parry SD, Stansfield R, Jelley D, et al. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective community-based, case-control study Am J Gastroenterol 2003; 98: 19705.
  • 20
    Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 2004; 99: 17748.
    Direct Link:
  • 21
    Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003; 125: 16519.
  • 22
    Mearin F, Perez-Oliveras M, Perello A, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005; 129: 98104.
  • 23
    Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM. for the WEL Investigators. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006; 131: 44550.
  • 24
    Chaudhary NA, Truelove SC. The irritable colon syndrome. Quart J Med 1962; 123: 30722.
  • 25
    Barbara G, Vallance BA, Collins SM. Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997; 113: 122432.
  • 26
    Halvorson HA, Schlett CD, Riddle MS. Post infectious irritable bowel syndrome – a meta-analysis. Am J Gastroenterol 2006; 101: 18949.
    Direct Link:
  • 27
    Marshall JK, Thabane M, Borgaonkar M, James C. Post-infectious irritable bowel syndrome following a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen. Clin Gastro Hepato, 2007; 5: 45760.
  • 28
    Stermer E, Lubezky A, Potasman I, Paster E, Lavy A. Is traveler’s diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 2006; 43: 898901. (Epub 2006 Aug. 25)
  • 29
    Parry SD, Stansfield R, Jelley D, et al. Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case–control study Am J Gastroenterol 2003; 98: 32731.
    Direct Link:
  • 30
    McKeown ES, Parry SD, Stansfield R, Barton JR, Welfare MR. Postinfectious irritable bowel syndrome may occur after non-gastrointestinal and intestinal infection. Neurogastroenterol Motil 2006; 18: 83943.
  • 31
    Parry SD, Barton JR, Welfare MR. Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role? Eur J Gastroenterol Hepatol 2005; 17: 10715.
  • 32
    Parry SD, Corbett S, James P, Barton JR, Welfare MR. Illness perceptions in people with acute bacterial gastro-enteritis. J Health Psychol 2003; 8: 693704.
  • 33
    Parry SD, Barton JR, Welfare MR. Is lactose intolerance implicated in the development of post-infectious irritable bowel syndrome or functional diarrhoea in previously asymptomatic people? Eur J Gastroenterol Hepatol 2002; 14: 122530.
  • 34
    Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003; 52: 5236.
  • 35
    Spence MJ, Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of gastroenteritis patients. Gut 2007; (Feb 26; Epub ahead of print).
  • 36
    Ouyang A, Wrzos HF. Contribution of gender to pathophysiology and clinical presentation of IBS: should management be different in women? Am J Gastroenterol 2006; 101(Suppl. 3): S6029.
    Direct Link:
  • 37
    Chang L, Toner BB, Fukudo S, et al. Gender, age, society, culture, and the patient’s perspective in the functional gastrointestinal disorders. Gastroenterology 2006; 130: 143546 (Review).
  • 38
    Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ. 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 92734. (Erratum in: Gastroenterology 1992; 102: 746).
  • 39
    Dinan TG, O’Keane V, O’Boyle C, Chua A, Keeling PW. A comparison of the mental status, personality profiles and life events of patients with irritable bowel syndrome and peptic ulcer disease. Acta Psychiatr Scand 1991; 84: 268.
  • 40
    Pinto C, Lele MV, Joglekar AS, Panwar VS, Dhavale HS. Stressful life-events, anxiety, depression and coping in patients of irritable bowel syndrome. J Assoc Physicians India 2000; 48: 58993.
  • 41
    Walker LS, Garber J, Smith CA, Van Slyke DA, Claar RL. The relation of daily stressors to somatic and emotional symptoms in children with and without recurrent abdominal pain. J Consult Clin Psychol 2001; 69: 8591.
  • 42
    Soyturk M, Akpinar H, Gurler O, et al. Irritable bowel syndrome in persons who acquired trichinellosis. Am J Gastroenterol 2007; 102: 10649.
    Direct Link:
  • 43
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 36170.
  • 44
    Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000; 95: 317683.
    Direct Link:
  • 45
    Mearin F, Badía X, Balboa A, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001; 36: 115561.
  • 46
    Drossman DA, Rome III: the functional gastrointestinal disorder, 3rd ed. McLean, VA: Degnon Associates, 2006.
  • 47
    Talley NJ, Phillips SF, Wiltgen CM, et al. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990; 65: 145679.
  • 48
    Drossman DA, Thompson WG, Talley NJ, et al. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int 1990; 3: 15972.
  • 49
    Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 6534.
  • 50
    Mearin F, Roset M, Badia X, et al. Splitting irritable bowel syndrome: from original Rome to Rome II criteria. Am J Gastroenterol 2004; 99: 12230.
    Direct Link:
  • 51
    Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002; 51: 103.
  • 52
    Decker MD, Booth AL, Dewey MJ, Fricker RS, Hutcheson RH Jr, Schaffner W. Validity of food consumption histories in a foodborne outbreak investigation. Am J Epidemiol 1986; 124: 85963.
  • 53
    Marks MI, Pai CH, Lafleur L, Lackman L, Hammerberg O. Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr 1980; 96: 2631.